¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ·

Study of Irinotecan and Bevacizumab With Temozolomide in Children With Central Nervous System Tumors

Clinical Trial</h3>\r\n<p><b>Offered by:</b> ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Health, Jacksonville<br>\r\n<b>Location:</b> Jacksonville, Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>A Phase I Study of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors</p>\r\n<h3>What is the trial about?</h3>\r\n<p>To determine safety and effectiveness temozolomide, irinotecan and bevacizumab. All three of these agents have shown effectiveness in pediatric brain tumors.</p>\r\n<h3>Who can participate?</h3>\r\n<ul>\r\n<li>Medulloblastoma, high-grade glioma, low-grade glioma, and ependymoma are eligible</li>\r\n<li>Adequate organ function</li>\r\n<li>Must have measurable disease</li>\r\n<li>Cannot have bleeding disorders</li>\r\n</ul>\r\n<h3>What is involved?</h3>\r\n<p>Length of study is up to 2 years. Standard cancer care.</p>\r\n"}} id=text-5997efe458 class=cmp-text>

Clinical Trial

Offered by: ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Health, Jacksonville
Location: Jacksonville, Florida

Trial Name

A Phase I Study of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors

What is the trial about?

To determine safety and effectiveness temozolomide, irinotecan and bevacizumab. All three of these agents have shown effectiveness in pediatric brain tumors.

Who can participate?

  • Medulloblastoma, high-grade glioma, low-grade glioma, and ependymoma are eligible
  • Adequate organ function
  • Must have measurable disease
  • Cannot have bleeding disorders

What is involved?

Length of study is up to 2 years. Standard cancer care.

Contact ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Clinical Trials

<strong>Trial Name: </strong>A Phase I Study of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors</p>\r\n<p><strong>IRB#</strong> 157862</p>\r\n"}} id=text-9eb76b6d81 class=cmp-text>

Trial Name: A Phase I Study of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors

IRB# 157862

Is a Clinical Trial Right for Your Child?</h2>"}} id=text-0752d1d632 class=cmp-text>

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.</p>\r\n"}} id=text-2abf51be48 class=cmp-text>

Learn more about clinical trials and get answers to questions you might have.

Two